Clearside Biomedical Announces Appointment of Gerald D. Cagle, Ph.D. to Board of Directors

Published: Jul 22, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Clearside Biomedical, Inc., a privately held ophthalmic company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases, today announced the appointment of Gerald D. Cagle, Ph.D., to the company’s Board of Directors. Dr. Cagle is the former Senior Vice President and Chief Scientific Officer of Alcon Laboratories, Inc.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news